We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Panel Says Generic Drug Launch Does Not Violate Patent Settlement

Mealey's (July 17, 2019, 12:35 PM EDT) -- PHILADELPHIA — A Delaware federal judge’s “thoughtful and thorough” decision rejecting breach of contract claims levied against a generic drug maker was affirmed July 16 by the Third Circuit U.S. Court...
To view the full article, register now.